tetano
Editor, Senior Moderator
PLoS One
. 2023 Apr 6;18(4):e0283658.
doi: 10.1371/journal.pone.0283658. eCollection 2023.
Underlying medical conditions and anti-SARS-CoV-2 spike IgG antibody titers after two doses of BNT162b2 vaccination: A cross-sectional study
Jiaqi Li[SUP] 1 [/SUP], Takeshi Nakagawa[SUP] 2 [/SUP], Masayo Kojima[SUP] 1 [/SUP], Akihiko Nishikimi[SUP] 3 [/SUP], Haruhiko Tokuda[SUP] 4 [/SUP], Kunihiro Nishimura[SUP] 5 [/SUP], Jun Umezawa[SUP] 6 [/SUP], Shiori Tanaka[SUP] 7 [/SUP], Manami Inoue[SUP] 6 7 [/SUP], Norio Ohmagari[SUP] 8 [/SUP], Koushi Yamaguchi[SUP] 9 [/SUP], Kazuyoshi Takeda[SUP] 10 [/SUP], Shohei Yamamoto[SUP] 11 [/SUP], Maki Konishi[SUP] 11 [/SUP], Kengo Miyo[SUP] 12 [/SUP], Tetsuya Mizoue[SUP] 11 [/SUP]
Affiliations
Abstract
Patients with underlying medical conditions are at high risk of developing serious symptoms of the coronavirus disease 2019 than healthy individuals; therefore, it is necessary to evaluate the immune response to vaccination among them to formulate precision and personalized vaccination strategies. However, inconsistent evidence exists regarding whether patients with underlying medical conditions have lower anti-SARS-CoV-2 spike IgG antibody titers. We performed a cross-sectional study enrolling 2762 healthcare workers who received second doses of BNT162b2 vaccination from three medical and research institutes between June and July, 2021. Medical conditions were surveyed by a questionnaire, and spike IgG antibody titers were measured with chemiluminescent enzyme immunoassay using serum collected on the median of 62 days after the second vaccination. Multilevel linear regression model was used to estimate geometric mean and ratio of mean (95% confidence interval, CI) for the presence and absence of medical conditions and treatments. Among all participants (median age, 40 years [interquartile range, 30-50]; male proportion, 29.4%), the prevalence of hypertension, diabetes, chronic lung disease, cardiovascular disease, and cancer was 7.5%, 2.3%, 3.8%, 1.8%, and 1.3%, respectively. Patients with treated hypertension had lower antibody titers than those without hypertension; the multivariable-adjusted ratio of mean (95% CI) was 0.86 (0.76-0.98). Patients with untreated and treated diabetes had lower antibody titers than those without diabetes; the multivariable-adjusted ratio of mean (95% CI) was 0.63 (0.42-0.95) and 0.77 (0.63-0.95), respectively. No substantial difference was observed between the presence or absence of chronic lung disease, cardiovascular disease, or cancer. Patients with untreated hypertension and patients with untreated and treated diabetes had lower spike IgG antibody titers than participants without those medical conditions, suggesting that continuous monitoring of antibody titers and further booster shots could be necessary to maintain adaptive immunity in patients with hypertension or diabetes.
. 2023 Apr 6;18(4):e0283658.
doi: 10.1371/journal.pone.0283658. eCollection 2023.
Underlying medical conditions and anti-SARS-CoV-2 spike IgG antibody titers after two doses of BNT162b2 vaccination: A cross-sectional study
Jiaqi Li[SUP] 1 [/SUP], Takeshi Nakagawa[SUP] 2 [/SUP], Masayo Kojima[SUP] 1 [/SUP], Akihiko Nishikimi[SUP] 3 [/SUP], Haruhiko Tokuda[SUP] 4 [/SUP], Kunihiro Nishimura[SUP] 5 [/SUP], Jun Umezawa[SUP] 6 [/SUP], Shiori Tanaka[SUP] 7 [/SUP], Manami Inoue[SUP] 6 7 [/SUP], Norio Ohmagari[SUP] 8 [/SUP], Koushi Yamaguchi[SUP] 9 [/SUP], Kazuyoshi Takeda[SUP] 10 [/SUP], Shohei Yamamoto[SUP] 11 [/SUP], Maki Konishi[SUP] 11 [/SUP], Kengo Miyo[SUP] 12 [/SUP], Tetsuya Mizoue[SUP] 11 [/SUP]
Affiliations
- PMID: 37023035
- DOI: 10.1371/journal.pone.0283658
Abstract
Patients with underlying medical conditions are at high risk of developing serious symptoms of the coronavirus disease 2019 than healthy individuals; therefore, it is necessary to evaluate the immune response to vaccination among them to formulate precision and personalized vaccination strategies. However, inconsistent evidence exists regarding whether patients with underlying medical conditions have lower anti-SARS-CoV-2 spike IgG antibody titers. We performed a cross-sectional study enrolling 2762 healthcare workers who received second doses of BNT162b2 vaccination from three medical and research institutes between June and July, 2021. Medical conditions were surveyed by a questionnaire, and spike IgG antibody titers were measured with chemiluminescent enzyme immunoassay using serum collected on the median of 62 days after the second vaccination. Multilevel linear regression model was used to estimate geometric mean and ratio of mean (95% confidence interval, CI) for the presence and absence of medical conditions and treatments. Among all participants (median age, 40 years [interquartile range, 30-50]; male proportion, 29.4%), the prevalence of hypertension, diabetes, chronic lung disease, cardiovascular disease, and cancer was 7.5%, 2.3%, 3.8%, 1.8%, and 1.3%, respectively. Patients with treated hypertension had lower antibody titers than those without hypertension; the multivariable-adjusted ratio of mean (95% CI) was 0.86 (0.76-0.98). Patients with untreated and treated diabetes had lower antibody titers than those without diabetes; the multivariable-adjusted ratio of mean (95% CI) was 0.63 (0.42-0.95) and 0.77 (0.63-0.95), respectively. No substantial difference was observed between the presence or absence of chronic lung disease, cardiovascular disease, or cancer. Patients with untreated hypertension and patients with untreated and treated diabetes had lower spike IgG antibody titers than participants without those medical conditions, suggesting that continuous monitoring of antibody titers and further booster shots could be necessary to maintain adaptive immunity in patients with hypertension or diabetes.